Back to dataset

UK Inflammatory Bowel Disease (IBD) audit: Round 4 (2012 - 2014) Data field description file paediatric biological therapies audit 2014

You're previewing the first 4 rows of this file.

Download this file
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 Column 9
Health board / Trust name Sitename Number of patients with Crohn's disease entered at your site Number of Crohn's disease follow-up treatments after initial infusion Response to treatment Remission achieved Patients with Crohn's disease treated with Infliximab appropriately prescribed in compliance with NICE criterion1.5 (TA187) Number of Crohn's disease patients with PROM data completed at initial treatment Number of Crohn's disease patients with PROM data completed at follow-up treatment
Name of Health Board / Trust Name of site No of Crohn's disease patients entered Number of Crohn's disease follow-up treatments after initial infusion Percentage (%) of Crohn's disease patients with a PCDAI drop of >=15 at any follow up between 10 and 14 weeks Percentage (%) of Crohn's disease patients with a PCDAI score of <=10 at any follow up between 10 and 14 weeks Percentage of patients with Crohn's disease treated with Infliximab appropriately prescribed in compliance with NICE criterion1.5 (TA187) Percentage of Crohn's disease patients with PROM data completed at initial treatment Percentage of Crohn's disease patients with PROM data completed at follow-up treatment
text text integer integer Percentage (Integer) Percentage (Integer) Percentage (Integer) Percentage (Integer) Percentage (Integer)
text text integer integer 0% (0) 0% (0) 0% (0) 0% (0) 0% (0)